Xilio Therapeutics's total assets for Q1 2025 were $103.72M, an increase of 45.92% from the previous quarter. XLO total liabilities were $93.02M for the fiscal quarter, a 73.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.